Stefan Dengl

12 Patents

• US122972632025

  Humanized Anti-tau(ps422) Antibodies and Methods of Use

  Hoffmann-la Roche Inc.

  0 cites
• US122972902025

  Method for Generating Multispecific Antibodies from Monospecific Antibodies

  Hoffmann-la Roche Inc.

  0 cites
• US122583712025

  Stabilized Immunoglobulin Domains

  Hoffman-la Roche Inc.

  0 cites
• US122525332025

  Anti-transferrin Receptor Antibodies with Tailored Affinity

  Hoffmann-la Roche Inc.

  0 cites
• US121577702024

  Anti-hla-g Antibodies and Methods of Use Thereof

  Hoffmann-la Roche Inc.

  0 cites
• US120233782024

  Covalently Linked Antigen-antibody Conjugates

  Hoffmann-la Roche Inc.

  0 cites
• US119817372024

  Anti-hla-g Antibodies and Use Thereof

  Hoffmann-la Roche Inc.

  0 cites
• US118664902024

  Antibody That Binds to VEGF and Il-1beta and Methods of Use

  Hoffmann-la Roche Inc.

  0 cites
• US118277112023

  Antibodies Binding to NKG2D

  Hoffmann-la Roche Inc.

  0 cites
• US118208162023

  Anti-vegf Antibodies and Methods of Use

  Hoffman-la Roche Inc.

  0 cites
• US115847932023

  Anti-transferrin Receptor Antibodies with Tailored Affinity

  Hoffmann-la Roche Inc.

  0 cites
• US115724042023

  Humanized Anti-tau(ps422) Antibodies and Methods of Use

  Hoffman-la Rocher Inc.

  0 cites